Muto, H.; Mizuno, F.; Honda, T.; Yokoyama, S.; Tanaka, T.; Yamamoto, K.; Ito, T.; Imai, N.; Ishizu, Y.; Sakai, K.;
et al. Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis. Metabolites 2025, 15, 366.
https://doi.org/10.3390/metabo15060366
AMA Style
Muto H, Mizuno F, Honda T, Yokoyama S, Tanaka T, Yamamoto K, Ito T, Imai N, Ishizu Y, Sakai K,
et al. Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis. Metabolites. 2025; 15(6):366.
https://doi.org/10.3390/metabo15060366
Chicago/Turabian Style
Muto, Hisanori, Fumitaka Mizuno, Takashi Honda, Shinya Yokoyama, Taku Tanaka, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Yoji Ishizu, Kiyoshi Sakai,
and et al. 2025. "Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis" Metabolites 15, no. 6: 366.
https://doi.org/10.3390/metabo15060366
APA Style
Muto, H., Mizuno, F., Honda, T., Yokoyama, S., Tanaka, T., Yamamoto, K., Ito, T., Imai, N., Ishizu, Y., Sakai, K., Hibi, H., Ishigami, M., & Kawashima, H.
(2025). Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis. Metabolites, 15(6), 366.
https://doi.org/10.3390/metabo15060366